
Yes, meningitis can cause serious illness and even death. But is it contagious?
Yes, meningitis can cause serious illness and even death. But is it contagious?
Show Caption
Hide Caption
Why Meningitis can be life threatening if not treated quickly
It is important to be aware of the signs and symptoms of meningitis to help identify it early and get prompt treatment.
unbranded - Lifestyle, unbranded - Lifestyle
Your body's brain and spinal cord are surrounded by three layers of membranes known as the meninges. These protective membranes are vital for providing structural support, cushioning tissue, improving circulation of cerebrospinal fluid and enhancing immune health by providing a defensive barrier against disease.
Meningitis is what happens when the meninges become infected and inflamed, leading to a host of worrisome symptoms that range in seriousness depending on what's causing the infection and inflammation. Some of these symptoms include a high fever, lethargy, hearing loss, kidney failure, confusion, brain damage, learning disabilities, coma and possibly death. "Other symptoms include irritability, unconsciousness, stiff neck, seizures, nausea/vomiting and sensitivity to light," says Dr. John Sellick, a professor of medicine in the infectious diseases division at the University at Buffalo.
Here's why there are such a wide variety of symptoms associated with meningitis and why not every form of meningitis is contagious.
What is meningitis?
There are multiple types of meningitis, which are typically classified by their cause. These include bacterial, viral, fungal, and parasitic. Viral meningitis is the more common form of the disease but is also generally considered the least dangerous. Viruses such as mumps, West Nile, HIV and the herpes simplex virus can all cause viral meningitis. More commonly though, viral meningitis is caused by a group of viruses known as enteroviruses.
Bacterial meningitis differs from viral meningitis as it's the least common but most dangerous type of meningitis. About one in six people who get it die, and one in five suffer severe complications, per the World Health Organization.
Bacterial meningitis is caused by bacteria entering the bloodstream and traveling to the meninges. Other times, this bacterial can enter the meninges directly due to a head injury or ear or sinus infection.
Fungal meningitis is caused by inhaling fungal spores such as ones found in bird droppings or decaying wood. It can cause death if not treated by antifungal medicine and is especially worrisome in people with compromised immune systems, says Dr. Jatin Vyas, a professor of medicine in the infectious disease division at the Columbia University Vagelos College of Physicians and Surgeons.
Parasitic meningitis can be caused by a tapeworm infection in the brain or by cerebral malaria. Rarely, an amoeba that lives in certain bodies of freshwater can enter the nose and travel to the brain.
Chemicals, allergies, adverse reactions to certain medications and some cancers can also cause meningitis. "Tuberculosis is another cause of meningitis, but tuberculous meningitis is rare in the United States," says Dr. Rodrigo Hasbun, an infectious diseases professor at the University of Texas McGovern Medical School.
Heads up: This type of meningitis is fast and deadly. Here's what to know.
Is meningitis contagious?
Some forms of meningitis are contagious while others are not. Parasitic, fungal and chemical meningitis, for instance, cannot be passed from person to person. Bacterial meningitis can be contagious, but it depends on which bacterial strain has caused the infection. Neisseria meningitidis bacteria, for instance, can not only be transmitted but is so contagious that "in many cases, persons who have been in close contact with patients with Neisseria meningitidis meningitis are given antibiotics to avoid infection," says Vyas.
The most easily transmitted type of the disease is viral meningitis, which can be passed directly from the infected individual when they cough or sneeze or by sharing the same cups or utensils or touching a surface the virus is on, then touching one's eyes, nose or mouth. Fecal-oral transmission can also occur if an infected person doesn't wash their hands and then contaminates surfaces. At the same time, not all forms of viral meningitis are contagious or spread easily. "West Nile Virus is transmitted by mosquito bites and not by human-to-human contact and the herpes simplex virus is only transmitted by unprotected sex," says Hasburn.
It's also worth noting, adds Vyas, that not all the contagious viruses related to meningitis will end up causing meningitis in every person they spread to.
Yes, exercise lowers blood pressure. This workout helps the most.
Can meningitis be prevented?
While not all forms of meningitis can be prevented in everyone, certain types can be avoided. Bacterial meningitis, for instance, can be prevented by getting vaccinated against the strains of bacteria that cause the disease. These include the Hib, MenB, MenACWY and PCV15 and PPSV23 vaccines, says Hasbun.
Some forms of viral meningitis can also be avoided by "excellent hand hygiene such as with alcohol hand rubs or hand washing," says Sellick. "Condom use can help you avoid herpes simplex and syphilis transmission," says Hasbun. It's also important to wear repellent when outdoors and to avoid the insects that can spread it, advises Sellick.
"Your healthcare provider can provide specific recommendations about which vaccines you need and how to best avoid meningitis in your area," says Vyas. "And if you develop signs and symptoms of any form of the disease, it's critical to seek prompt medical care."
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Trump to slash funding for flagship US HIV programme by 40pc
America is proposing to cut its flagship anti-HIV programme by almost 40 per cent next year, according to new budget details that reveal sweeping reductions to global health spending. Details from Donald Trump's 2026 budget request show nearly a two-fifths fall in funding for the United States President's Emergency Plan for Aids Relief (Pepfar). The long-running programme is estimated to have saved more that 20 million lives in the past two decades, and is often cited as one of the world's most successful public health schemes. A recent analysis published in the Lancet found that as many as half a million more children could die from Aids by the end of the decade because of disruptions to Pepfar. The details on global health funding for the State Department, USAID agency, Centres for Disease Control and Prevention (CDC), and the National Institutes of Health (NIH) also show deep cuts elsewhere. Analysis by the San Francisco-based KFF health policy charity found the government departments were planning a 55 per cent cut in separate tuberculosis funding, a 47 per cent cut in malaria funding and a 92 per cent cut in maternal health funding. The proposal also withdraws all £221m ($300m) given to Gavi, the vaccine alliance which provides jabs to children in poor countries. In total, the request for money for the American government's main global health funding account is £2.8bn ($3.8bn) in 2026, down from £7.4bn ($10bn) in 2025. Setting out the cuts, the State Department said the request for money 'eliminates funding for programmes that do not make Americans safer, such as family planning and reproductive health, neglected tropical diseases, and non-emergency nutrition'. Mr Trump's government upended US aid spending days after taking office, saying it would suspend all aid while projects were reviewed. It then proceeded to close hundreds of aid programmes, including Pepfar projects, resulting in lay-offs for thousands of health workers, particularly in Africa. The budget proposals now give a clear indication that Mr Trump intends to continue with sharp cuts and will quash any hopes that the funding taps could be switched back on again. A State Department explanation of the budget request uses the phrase 'America First' 37 times as it explains a new focus on cutting costs and protecting US national interests. For the 2026 fiscal year, which begins on Oct 1, the budget proposals request £2.1bn ($2.9bn) for Pepfar, a 38 per cent reduction from the £3.5bn ($4.7bn) requested in 2025. The State department said that after spending a total of £88bn ($120bn) in the past two decades, it was now focussing on finding a responsible 'off ramp' to hand over responsibility for the campaign against HIV to countries themselves. 'This [budget] request will allow the United States to accelerate the transition of HIV control programmes to recipient countries and increase international ownership of efforts to fight HIV/Aids.' Some projects may still be paid for by other government funds, but overall the KFF analysis found the budget included 'significant reductions in global health funding including the elimination of some programs and activities'. The details will prove a severe disappointment to aid projects who had hoped that despite Mr Trump's rhetoric, there was a chance funding could be renewed in the new fiscal year. Public health officials argue that continuing to fund global health projects to stamp out infectious diseases is still in America's best interests as infections often cross borders. One executive at a major South African anti-HIV organisation said: 'Nobody wins unless we all win. No one can make it out of this alone. This is how we achieve epidemic control.' Protect yourself and your family by learning more about Global Health Security Broaden your horizons with award-winning British journalism. Try The Telegraph free for 1 month with unlimited access to our award-winning website, exclusive app, money-saving offers and more.
Yahoo
an hour ago
- Yahoo
Popular Mineral Water Sold at Costco Recalled Over Bacterial Contamination
Coca-Cola has issued a voluntary recall of 18-packs of 16.9-ounce glass Topo Chico mineral water due to possible contamination with Pseudomonas, a bacterium that can cause serious infections in people with weakened immune systems. The recall affects products sold between May 20 and May 29 at 40 Costco locations across five states: Arizona, Louisiana, Nevada, New Mexico, and Texas. The impacted lot is labeled '#13A2541.' No illnesses have been reported, and Coca-Cola states that the health risk is very low for the general population. Affected customers can return the product to Costco for a full you recently purchased any Topo Chico mineral water, then it's time to check your fridge or pantry. On Wednesday, Coca-Cola issued a voluntary recall of its Topo Chico mineral water in five states due to concerns about potential contamination with a deadly bacteria for individuals with weakened immune systems known as Pseudomonas. As the Centers for Disease Control and Prevention (CDC) explains, Pseudomonas is a group of bacteria that is "commonly found in the environment, like in soil and water." However, if it flourishes, it can "cause infections in the blood, lungs (pneumonia), urinary tract, or other parts of the body after surgery." A spokesperson confirmed to USA Today that the bottles were shipped to 40 retail locations across Arizona, Louisiana, Nevada, New Mexico, and Texas, with Costco included among the affected retailers. Individuals who purchased contaminated Topo Chico are encouraged to return them to their local Costco for a full refund. Those who have further questions can call Coca-Cola at 1-800-GET-COKE (1-800-438-2653). Related: The Food Recall System Is Broken, and Experts Say We're All at Risk According to the brand's letter sent to Costco members on June 2, the recalled product bears the Lot Code #13A2541 on both the outer box and the neck of each bottle. It specifically affects the 18-packs of glass 16.9-ounce Topo Chico mineral water. The notice from Coca-Cola also stated that if you purchased one of the recalled packages, you can return it to your nearest Costco for a full refund. A Costco spokesperson noted that the products were all purchased between May 20 and May 29. No illnesses have been reported in connection with the recall. Coca-Cola also noted that the health consequences for those who accidentally consume the mineral water containing pseudomonas are "very low." However, the CDC advises that those most at risk include anyone on "breathing machines, have devices such as catheters, [or] have open wounds from surgery or burns." The Cleveland Clinic additionally noted that "It's rare for a Pseudomonas aeruginosa infection to develop in people with a healthy immune system. But it can be serious and potentially deadly if you have a weakened immune system (immunocompromised)." That includes individuals living with conditions such as lupus, rheumatoid arthritis, cancer, HIV, diabetes, liver disease, or those who are pregnant. Symptoms of an infection may include fever, chills, muscle pain, earache, headache, nausea, or vomiting. If you experience any symptoms, seek out a medical expert immediately. Product recalled: 18-packs of glass 16.9-ounce Topo Chico mineral waterReason for recall: Potential Pseudomonas contaminationLot Code: #13A2541 States affected: Arizona, Louisiana, Nevada, New Mexico, and TexasStores affected: 40 separate Costco locationsRead the original article on Food & Wine


Forbes
2 hours ago
- Forbes
Experts Warn Of Decade-Long Setback After Trump Cuts HIV Vaccine Research
NEW YORK - DECEMBER 1: Marina Kemelman, Research Associate at the AIDS Vaccine Design and ... More Development Laboratory, collects bacteria transfected with DNA as part of research at the laboratory's campus in the former Brooklyn Army Terminal December 1, 2008 in New York City. The laboratory, seeking a vaccine to prevent the spread of AIDS, is part of the International AIDS Vaccine Initiative (or IAVI), a global not-for-profit, public-private partnership working to accelerate the development of a vaccine to prevent HIV infection and AIDS. December 1 is the 20th annual World AIDS Day around the world. (Photo by) It was a rare moment of bipartisan unity. Standing before a joint session of Congress in January 2019, President Donald Trump boldly pledged to eradicate a disease that claims one life every single minute: HIV/AIDS. 'Scientific breakthroughs have brought a once-distant dream within reach,' Trump exclaimed. 'My budget will ask Democrats and Republicans to make the needed commitment to eliminate the HIV epidemic in the United States within 10 years. We have made incredible strides.' Then, he added, 'we will defeat AIDS in America and beyond.' That was then and this is now. Last week, a group of scientists working on promising HIV vaccine studies were reportedly informed that the administration plans to revoke their research grants in a move experts warn could set the movement back years. When the global AIDS crisis peaked in the early 2000s, roughly 5,000 people were dying every single day from the disease. Thanks to the leadership of governments, the private sector, and philanthropists, the world invested more resources into the AIDS fight than ever before. This spurred nearly two decades of progress—not just against AIDS, but across global health broadly. Since 2004, AIDS-related deaths have been reduced by roughly two-thirds. But recently, progress has slowed. Covid-19 proved a major health disruption that reversed years of hard-fought gains. Efforts to reduce mother-to-child transmission rates have slowed. Global health funding is now under siege not just in the United States, but across Europe, too. And the world is no longer on track to meet critical 2030 AIDS targets. The great paradox here is that never in human history has there been more tools available to fight AIDS. The cost of antiretroviral drugs has fallen from $27 a day in 2000 to as little as 10 cents a day. Now, experts say what's needed to get the fight back on track—and eventually end the threat for good—isn't just better diagnostics and therapeutics, but long acting preventatives. Fortunately, it's an area that's seen great progress. Dubbed the 'breakthrough of the year' in 2024 by the journal Science, Gilead Science's lenacapavir is a long-acting injectable vaccine that has proven incredibly effective at preventing HIV infections. It represents a major step forward from the prevalent pre-exposure prophylaxis (PrEP) pill and mitigates some of the major privacy, stigma, and adherence issues that come with taking daily medication. The next step forward could be a vaccine with even longer immunity—one that gives patients lifetime protection. Researchers have been pursuing this laudable goal for years, but last week, the Trump administration announced plans to terminate research grants at two preeminent institutions, the Duke Human Vaccine Institute and the Scripps Research Institute, totaling $258 million. The researchers were told that the administration wanted 'to go with currently available approaches to eliminate HIV.' On the other hand, global health experts are warning that without new resources, President Trump's promise to end HIV within ten years is destined to fail—and when combined with the administration's other actions to cut and halt global health programs, HIV infections and deaths could actually rise for the first time in decades under his watch. 'I find it very disappointing that, at this critical juncture, the funding for highly successful H.I.V. vaccine research programs should be pulled,' Dennis Burton, an immunologist at Scripps, told The New York Times. Meanwhile AIDS groups, including the AIDS Vaccine Advocacy Coalition described the decision as inconceivable and shortsighted. The grant news marks the latest blow to the HIV/AIDS community, which has endured devastating domestic and global funding cuts in Trump's second term. San Francisco, which was one of the first epicenters of the domestic AIDS fight, has long relied on funding from the federal government to support community-based health programs that help reduce HIV transmission. These initiatives have helped the city make outstanding progress against the disease, but Centers for Disease Control and Prevention (CDC) grant delays have threatened testing, treatment, and care continuity. Even southern states which President Trump won decisively, and which account for 50% of all new U.S. HIV infections, have not been spared. According to the Foundation for AIDS Research (amfAR), cuts to domestic HIV prevention programs could spark over 14,000 additional deaths from AIDS-related causes and 143,000 new HIV infections. Earlier this year, HHS closed its Office of Infectious Diseases & HIV policy that quarterbacked the government's domestic AIDS response. Abroad, global health programs have fared even worse. In January, the Trump administration halted funding for The President's Emergency Plan for AIDS Relief (PEPFAR), a bipartisan program that has saved over 26 million lives. In a congressional hearing last week, Secretary of State Marco Rubio said that, '85 percent of recipients are now receiving PEPFAR services.' He also said that no one has died as a result of the aid freeze, a notion journalists and health experts scoff at. According to Brooke Nichols, an infectious disease mathematical modeler and health economist at Boston University, over 57,000 adults and 6,000 children have died as a result of the PEPFAR funding freeze and the discontinuation of global health programs. Even if those numbers are inflated, as some have contended, the number of lives needlessly lost is still likely in the tens of thousands. While some experts remain hopeful that the recent cuts will eventually be restored, the prospect of an AIDS-free future that President Trump himself once espoused appears grim. "This is a decision with consequences that will linger. This is a setback of probably a decade for HIV vaccine research," Burton warned.